Namwiwat Medical PCL (BKK:NAM) Interest Expense: ฿-21 Mil (TTM As of Mar. 2026)


BKK:NAM Namwiwat Medical Corp PCL BKK:NAM
39 GF Score
Price ฿3.44
GF Value ฿6.03
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Namwiwat Medical PCL Interest Expense?

Namwiwat Medical PCL BKK:NAM 39 Interest Expense is ฿-21 Mil as of Mar. 2026. GuruFocus rates BKK:NAM with a GF Score™ of 39/100 and a GF Value™ of ฿6.03 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Namwiwat Medical PCL's interest expense for the three months ended in Mar. 2026 was ฿ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-21 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Namwiwat Medical PCL's Operating Income for the three months ended in Mar. 2026 was ฿ 19 Mil. Namwiwat Medical PCL's Interest Expense for the three months ended in Mar. 2026 was ฿ -4 Mil. Namwiwat Medical PCL's Interest Coverage for the quarter that ended in Mar. 2026 was 4.40. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Namwiwat Medical PCL  (BKK:NAM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Namwiwat Medical PCL's Interest Expense for the three months ended in Mar. 2026 was ฿-4 Mil. Its Operating Income for the three months ended in Mar. 2026 was ฿19 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ฿135 Mil.

Namwiwat Medical PCL's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*18.803/-4.272
=4.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Namwiwat Medical PCL Interest Expense Historical Data

* Premium members only.

The historical data trend for Namwiwat Medical PCL's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Namwiwat Medical PCL Interest Expense Chart

Namwiwat Medical PCL Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial -14.03 -12.99 -15.73 -12.68 -23.33

Namwiwat Medical PCL Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.90 -6.53 -7.89 -2.01 -4.27
BKK:NAM
39GF Score
Namwiwat Medical Corp PCL BKK:NAM
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Namwiwat Medical PCL Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ฿-21 Mil mean?
Namwiwat Medical PCL (BKK:NAM) has a Interest Expense of ฿-21 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Namwiwat Medical PCL and its competitors.
Is Namwiwat Medical PCL's Interest Expense too high?
Namwiwat Medical PCL's current Interest Expense is ฿-21 Mil. Overall, Namwiwat Medical PCL has a GF Score™ of 39/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Namwiwat Medical PCL's Interest Expense compare to ABT and SYK?
Namwiwat Medical PCL's Interest Expense of ฿-21 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Namwiwat Medical PCL and its competitors. Namwiwat Medical PCL's current Interest Expense is ฿-21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Namwiwat Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Namwiwat Medical PCL (BKK:NAM) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿6.03, compared to a current price of ฿3.44 — trading 43% below its estimated fair value. The current Interest Expense is ฿-21 Mil. Namwiwat Medical PCL's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Namwiwat Medical PCL (BKK:NAM), the current Interest Expense is ฿-21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Namwiwat Medical PCL (BKK:NAM) Overvalued in 2026?

Based on GuruFocus' analysis, Namwiwat Medical PCL stock appears to be undervalued. The current stock price of ฿3.44 is trading 43% below its estimated GF Value™ of ฿6.03. GuruFocus considers Namwiwat Medical PCL to be Significantly Undervalued.

Key valuation signals for BKK:NAM:

  • Interest Expense: ฿-21 Mil
  • GF Value™: ฿6.03 vs. price of ฿3.44 (43% below fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the BKK:NAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Namwiwat Medical PCL Business Description

Address 999/3-5 Moo 9 Prachauthit - Ku Sang Road, Nai Khlong Bang Pla Kot, Phra Samut Chedi, Samut Prakan, THA, 10290
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
39GF Score

Get the complete analysis for BKK:NAM

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.44
Price
฿6.03
GF Value